European Commission Faces Backlash Over Insufficient Disclosure of COVID-19 Vaccine Agreements

The European Commission has been criticized for not providing the public with adequate information about the deals to purchase COVID-19 vaccines from pharmaceutical companies during the pandemic. This criticism comes from a decision by the Court of the European Union (CJEU), announced today.

The court's decision is particularly significant as it comes just a day before the European Parliament in Strasbourg is set to vote on Ursula von der Leyen’s candidacy for a second term as President of the European Commission....